These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 25709892)
1. Effects of 5-azacytidine on natural killer cell activating receptor expression in patients with refractory anemia with excess of blasts. Costello RT; Leclercq A; Treut TL; Sanchez C; Mercier D; Sébahoun G Leuk Res Rep; 2015; 4(1):15-7. PubMed ID: 25709892 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms accounting for the impaired natural-killer cell activity in refractory anaemia with excess of blasts. Eliopoulos GD; Coulocheri SA; Eliopoulos AG; Katrinakis G; Karkavitsas N; Kyriakou D; Vaiopoulos G; Foudoulakis A Eur J Haematol; 1992 May; 48(5):237-43. PubMed ID: 1379537 [TBL] [Abstract][Full Text] [Related]
3. Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions. Kopp LM; Ray A; Denman CJ; Senyukov VS; Somanchi SS; Zhu S; Lee DA Mol Immunol; 2013 Jul; 54(3-4):296-301. PubMed ID: 23328088 [TBL] [Abstract][Full Text] [Related]
4. Immunotyping of blasts in refractory anaemia with excess of blasts. Oertel J; Kleiner S; Huhn D Br J Haematol; 1993 Jun; 84(2):305-9. PubMed ID: 7691147 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-2 therapy for myelodysplastic syndrome: does it work? Ogata K; Yokose N; Nomura T Leuk Lymphoma; 1995 May; 17(5-6):411-5. PubMed ID: 7549831 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic challenges related to myeloid/natural killer cells, a variant of myeloblasts. Tang G; Truong F; Fadare O; Woda B; Wang SA Int J Clin Exp Pathol; 2008 Jan; 1(6):544-9. PubMed ID: 18787634 [TBL] [Abstract][Full Text] [Related]
7. Susceptibility to Infection Due to Diminished Interferon-α-Producing Capacity in Patients with Refractory Anemia with Excess of Blasts or Refractory Anemia with Excess of Blasts in Transformation. Maruo N; Uno K; Kishi A; Ueda T; Takahashi T; Ito T; Kishida T Hematology; 1997; 2(2):131-8. PubMed ID: 27406803 [TBL] [Abstract][Full Text] [Related]
8. Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer Cells. Dulphy N; Chrétien AS; Khaznadar Z; Fauriat C; Nanbakhsh A; Caignard A; Chouaib S; Olive D; Toubert A Front Immunol; 2016; 7():94. PubMed ID: 27014273 [TBL] [Abstract][Full Text] [Related]
9. Sanchez-Correa B; Bergua JM; Pera A; Campos C; Arcos MJ; Bañas H; Duran E; Solana R; Tarazona R Front Immunol; 2017; 8():931. PubMed ID: 28824651 [TBL] [Abstract][Full Text] [Related]
10. Azacytidine impairs NK cell reactivity while decitabine augments NK cell responsiveness toward stimulation. Schmiedel BJ; Arélin V; Gruenebach F; Krusch M; Schmidt SM; Salih HR Int J Cancer; 2011 Jun; 128(12):2911-22. PubMed ID: 20960460 [TBL] [Abstract][Full Text] [Related]
11. Alpha-interferon in myelodysplasia; clinical observations and effects on NK cells. Galvani DW; Nethersell AB; Cawley JC Leuk Res; 1988; 12(3):257-62. PubMed ID: 3163399 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of clonal chromosomal abnormalities in patients with primary myelodysplastic syndromes. Gyger M; Infante-Rivard C; D'Angelo G; Forest L; Lussier P Am J Hematol; 1988 May; 28(1):13-20. PubMed ID: 3369432 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic suppression of the antitumor cytotoxicity of NK cells by histone deacetylase inhibitor valproic acid. Shi X; Li M; Cui M; Niu C; Xu J; Zhou L; Li W; Gao Y; Kong W; Cui J; Hu J; Jin H Am J Cancer Res; 2016; 6(3):600-14. PubMed ID: 27152238 [TBL] [Abstract][Full Text] [Related]
14. Demethylating treatment suppresses natural killer cell cytolytic activity. Gao XN; Lin J; Wang LL; Yu L Mol Immunol; 2009 Jun; 46(10):2064-70. PubMed ID: 19394699 [TBL] [Abstract][Full Text] [Related]
15. Deficiency of lymphocyte lectin-dependent cytotoxicity in myelodysplastic syndromes. Fontana L; De Sanctis G; De Rossi G; Bottari V; Petti MC; Ensoli F; Pasqualetti D; Mandelli F Acta Haematol; 1989; 82(1):1-6. PubMed ID: 2505468 [TBL] [Abstract][Full Text] [Related]
16. Loss of chromosome 22 in patients with refractory anemia with excess of blasts (RAEB) in transformation and acute leukemia after RAEB. Berger R; Le Coniat M; Derré J; Flexor MA Cancer Genet Cytogenet; 1992 Jul; 61(2):210-2. PubMed ID: 1638507 [TBL] [Abstract][Full Text] [Related]
17. [Effect of demethylating treatment on cytotoxicity of NK-92MI cells]. Gao XN; Wang LL; Lin J; Yu L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):924-8. PubMed ID: 19698230 [TBL] [Abstract][Full Text] [Related]
18. Effect of recombinant alpha-interferon administration on peripheral blood lymphocyte subpopulations and natural killer cell activity in patients with refractory anemia with excess of blasts. Eliopoulos G; Coulocheri S; Vaiopoulos G; Alexandrakis M; Ganotakis E; Eliopoulos A; Yataganas X Nouv Rev Fr Hematol (1978); 1991; 33(1):21-4. PubMed ID: 1945821 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia. Sandoval-Borrego D; Moreno-Lafont MC; Vazquez-Sanchez EA; Gutierrez-Hoya A; López-Santiago R; Montiel-Cervantes LA; Ramírez-Saldaña M; Vela-Ojeda J Arch Med Res; 2016 Jan; 47(1):55-64. PubMed ID: 26876298 [TBL] [Abstract][Full Text] [Related]
20. More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia. Huh YO; Jilani I; Estey E; Giles F; Kantarjian H; Freireich E; Albitar M Leukemia; 2002 Nov; 16(11):2249-52. PubMed ID: 12399969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]